Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies a...( NEW YORK Nov. 3 /- Reportlinker.com a...),Health

NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Gastrointestinal Pharmaceuticals: Technologies and Markets

http://www.reportlinker.com/p0157462/Gastrointestinal-Pharmaceuticals-Technologies-and-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billion in 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.

The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.

Chapter- 1: INTRODUCTION -- Complimentary

STUDY GOALS AND OBJECTIVES 1

REASONS FOR DOING THE STUDY 1

INTENDED AUDIENCE 1

SCOPE OF REPORT 2

METHODOLOGY AND INFORMATION SOURCES 2

ANALYST CREDENTIALS 3

RELATED BCC REPORTS 3

BCC ONLINE SERVICES 4

DISCLAIMER 4

Chapter-2: EXECUTIVE SUMMARY

EXECUTIVE SUMMARY 5

SUMMARY TABLE GLOBAL PRESCRIPTION AND OTC GASTROINTESTINAL DISORDER TREATMENT MARKET, THROUGH 2014 ($ MILLIONS) 6

SUMMARY FIGURE GLOBAL
'/>"/>